SI9300685A - Cephalosorins salts and procedure for their preparation - Google Patents
Cephalosorins salts and procedure for their preparation Download PDFInfo
- Publication number
- SI9300685A SI9300685A SI9300685A SI9300685A SI9300685A SI 9300685 A SI9300685 A SI 9300685A SI 9300685 A SI9300685 A SI 9300685A SI 9300685 A SI9300685 A SI 9300685A SI 9300685 A SI9300685 A SI 9300685A
- Authority
- SI
- Slovenia
- Prior art keywords
- cephalosporin
- salt
- methyl
- cefotaxime
- salts
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D333/40—Thiophene-2-carboxylic acid
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cephalosporin Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4244069A DE4244069A1 (de) | 1992-12-24 | 1992-12-24 | Cephalosporinsalze und Verfahren zu deren Herstellung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI9300685A true SI9300685A (en) | 1994-06-30 |
Family
ID=6476531
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI9300685A SI9300685A (en) | 1992-12-24 | 1993-12-24 | Cephalosorins salts and procedure for their preparation |
Country Status (27)
| Country | Link |
|---|---|
| EP (1) | EP0603755A3 (fi) |
| JP (1) | JPH06247974A (fi) |
| KR (1) | KR940014406A (fi) |
| CN (1) | CN1093089A (fi) |
| AU (1) | AU672056B2 (fi) |
| BR (1) | BR9305213A (fi) |
| CA (1) | CA2112196A1 (fi) |
| CZ (1) | CZ285693A3 (fi) |
| DE (1) | DE4244069A1 (fi) |
| EC (1) | ECSP930947A (fi) |
| FI (1) | FI935797A (fi) |
| HR (1) | HRP931517A2 (fi) |
| HU (1) | HUT66141A (fi) |
| IL (1) | IL108134A0 (fi) |
| MA (1) | MA23070A1 (fi) |
| MX (1) | MX9308061A (fi) |
| NO (1) | NO934791L (fi) |
| NZ (1) | NZ250547A (fi) |
| OA (1) | OA09846A (fi) |
| PL (1) | PL301623A1 (fi) |
| SI (1) | SI9300685A (fi) |
| SK (1) | SK146293A3 (fi) |
| TN (1) | TNSN93138A1 (fi) |
| TW (1) | TW353662B (fi) |
| UY (1) | UY23683A1 (fi) |
| YU (1) | YU80593A (fi) |
| ZA (1) | ZA939609B (fi) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR0210357A (pt) | 2001-06-11 | 2004-06-29 | Shire Biochem Inc | Composto e métodos para o tratamento ou a prevenção de infecções pelo flavivìrus |
| US8329924B2 (en) | 2001-06-11 | 2012-12-11 | Vertex Pharmaceuticals (Canada) Incorporated | Compounds and methods for the treatment or prevention of Flavivirus infections |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1643325B2 (de) * | 1967-07-07 | 1976-05-06 | Hoechst Ag, 6000 Frankfurt | 3-aminoacylaminothiophene und verfahren zu ihrer herstellung |
-
1992
- 1992-12-24 DE DE4244069A patent/DE4244069A1/de not_active Withdrawn
-
1993
- 1993-06-28 EC EC1993000947A patent/ECSP930947A/es unknown
- 1993-09-17 TW TW082107623A patent/TW353662B/zh active
- 1993-12-09 UY UY23683A patent/UY23683A1/es unknown
- 1993-12-16 MX MX9308061A patent/MX9308061A/es unknown
- 1993-12-17 EP EP9393120375A patent/EP0603755A3/en not_active Withdrawn
- 1993-12-21 CZ CZ932856A patent/CZ285693A3/cs unknown
- 1993-12-22 YU YU80593A patent/YU80593A/sh unknown
- 1993-12-22 IL IL10813493A patent/IL108134A0/xx unknown
- 1993-12-22 ZA ZA939609A patent/ZA939609B/xx unknown
- 1993-12-22 AU AU52667/93A patent/AU672056B2/en not_active Ceased
- 1993-12-22 JP JP5323921A patent/JPH06247974A/ja active Pending
- 1993-12-22 CA CA002112196A patent/CA2112196A1/en not_active Abandoned
- 1993-12-22 NZ NZ250547A patent/NZ250547A/en unknown
- 1993-12-22 SK SK1462-93A patent/SK146293A3/sk unknown
- 1993-12-22 FI FI935797A patent/FI935797A/fi not_active Application Discontinuation
- 1993-12-23 BR BR9305213A patent/BR9305213A/pt not_active Application Discontinuation
- 1993-12-23 CN CN93112787A patent/CN1093089A/zh active Pending
- 1993-12-23 NO NO934791A patent/NO934791L/no unknown
- 1993-12-23 HU HU9303747A patent/HUT66141A/hu unknown
- 1993-12-23 HR HR931517A patent/HRP931517A2/hr not_active Application Discontinuation
- 1993-12-23 TN TNTNSN93138A patent/TNSN93138A1/fr unknown
- 1993-12-23 PL PL93301623A patent/PL301623A1/xx unknown
- 1993-12-24 MA MA23380A patent/MA23070A1/fr unknown
- 1993-12-24 OA OA60452A patent/OA09846A/fr unknown
- 1993-12-24 KR KR1019930029471A patent/KR940014406A/ko not_active Application Discontinuation
- 1993-12-24 SI SI9300685A patent/SI9300685A/sl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX9308061A (es) | 1994-06-30 |
| AU672056B2 (en) | 1996-09-19 |
| ECSP930947A (es) | 1994-11-16 |
| FI935797A (fi) | 1994-06-25 |
| NO934791L (no) | 1994-06-27 |
| KR940014406A (ko) | 1994-07-18 |
| NZ250547A (en) | 1995-08-28 |
| IL108134A0 (en) | 1994-04-12 |
| HRP931517A2 (en) | 1994-12-31 |
| HU9303747D0 (en) | 1994-04-28 |
| TNSN93138A1 (fr) | 1994-03-17 |
| NO934791D0 (no) | 1993-12-23 |
| OA09846A (fr) | 1994-08-15 |
| EP0603755A3 (en) | 1994-09-28 |
| EP0603755A2 (de) | 1994-06-29 |
| YU80593A (sh) | 1996-10-09 |
| ZA939609B (en) | 1994-08-11 |
| FI935797A0 (fi) | 1993-12-22 |
| TW353662B (en) | 1999-03-01 |
| BR9305213A (pt) | 1994-07-26 |
| PL301623A1 (en) | 1994-06-27 |
| SK146293A3 (en) | 1994-12-07 |
| DE4244069A1 (de) | 1994-06-30 |
| JPH06247974A (ja) | 1994-09-06 |
| CN1093089A (zh) | 1994-10-05 |
| HUT66141A (en) | 1994-09-28 |
| UY23683A1 (es) | 1993-12-17 |
| MA23070A1 (fr) | 1994-07-01 |
| CA2112196A1 (en) | 1994-06-25 |
| AU5266793A (en) | 1994-07-07 |
| CZ285693A3 (en) | 1994-07-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101290893B1 (ko) | 피롤리디늄 염의 제조 방법 | |
| EP0272052B1 (en) | Anxiolytic-N-(1-Azabicyclo[2.2.2]Oct-3-yl) Benzamides and Thobenzamides | |
| RU2125571C1 (ru) | СОЛЬ 7-([1α,5α,6α]-6-АМИНО-3-АЗАБИЦИКЛО [3.1.0] ГЕКС-3-ИЛ)-6-ФТОР-1-(2,4-ДИФТОРФЕНИЛ)-1,4- ДИГИДРО-4-ОКСО-1,8-НАФТИРИДИН-3-КАРБОНОВОЙ И МЕТАНСУЛЬФОНОВОЙ КИСЛОТ И СПОСОБ ЕЕ ПОЛУЧЕНИЯ | |
| EP0528922B1 (de) | Neue sulfonylverbindungen | |
| WO2005063714A1 (en) | Analogs of benzoquinone-containing ansamycins for the treatment of cancer | |
| EP0579681B1 (en) | Crystalline tiagabine hydrochloride monohydrate, its preparation and use | |
| SK24389A3 (en) | Crystalline additive salts of 7-alpha[(2-aminothiazol-4-yl)- -alpha-(z)-methoxyiminoacetamido]-3-[(1-methyl-1- -pyrrolidino)methyl]-3-cephem-4-carboxylate, method for producing and pharmaceutical compositions comprising same | |
| RU2609006C2 (ru) | Способ получения пеметрекседа и его лизиновой соли | |
| KR20180136741A (ko) | 알킬카바모일 나프탈렌일옥시 옥테노일 하이드록시아마이드 또는 그 유도체의 약학적으로 허용 가능한 염 및 그 제조방법 | |
| CS207646B2 (en) | Method of making the crystallic hydrated form of the sodium salt of the oximine derivative of the 7-aminothiazolylacetamidocephalosporan acid | |
| CH647519A5 (de) | Bluthochdruck senkende amine. | |
| SI9300685A (en) | Cephalosorins salts and procedure for their preparation | |
| AU607136B2 (en) | Beta-lactam antibiotics | |
| HU179391B (en) | Process for producing thiasolo-square bracket-2,3-b-square bracket closed-quinasoline derivatives | |
| KR20010052866A (ko) | 3-(2-옥소-[1,3']비피롤리디닐-3-일리덴메틸)-세펨의 유도체 | |
| CZ401998A3 (cs) | Modifikovaná forma hydrochloridu R(-)-N-(4,4-di(3-methylthien-2-yl)but-3-enyl)nipekotové kyseliny | |
| AU704115B2 (en) | Zwitterionic forms of trovafloxacin | |
| KR100696422B1 (ko) | 항생물질로서 사이클릭 아미노구아니딘 치환체를 가진세팔로스포린 | |
| US6066647A (en) | Zwitterionic forms of trovafloxacin | |
| EP0122376A1 (en) | Anticholinesterase pyridine derivatives | |
| PL185709B1 (pl) | Nowy monohydrat polimorfu II 6-N-(L-Ala-L-Ala)-trowafloksacyny i środek farmaceutyczny | |
| FI80034C (fi) | Foerfarande foer framstaellning av terapeutiskt anvaendbara mjoeldrygaalkaloider. | |
| PT86178B (pt) | Processo para a preparacao de benzo{g}quinolinas | |
| CZ350492A3 (en) | Benzoquinoxaline derivatives, process of their preparation and a pharmaceutical composition in which said derivatives are contained | |
| SI21067A2 (sl) | Amlodipin hemimaleat |